Gastric Insufflation and Laryngeal Mask Airway

NCT ID: NCT02097771

Last Updated: 2014-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of the incidence of gastric insufflation between two kinds of laryngeal masks airways: LMA SupremeTM vs Ambu AuraOnceTM

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Insufflation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LMA SupremeTM

Group Type ACTIVE_COMPARATOR

LMA SupremeTM

Intervention Type DEVICE

Ambu AuraOnce

Group Type SHAM_COMPARATOR

AuraOnceTM

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LMA SupremeTM

Intervention Type DEVICE

AuraOnceTM

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA 1 or 2
* Age \> 18 yrs
* Use of laryngeal mask airway required

Exclusion Criteria

* risk of pulmonary aspiration of gastric contents
* Contraindication for the use of laryngeal mask airway
* Tracheal intubation required
* Patient's refusal
Minimum Eligible Age

18 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lionel Bouvet

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lionel Bouvet

MD PhD

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospices Civils de Lyon

Lyon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lionel Bouvet

Role: CONTACT

+33 4 72 11 69 88

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bouvet

Role: primary

+ 33 4 72 11 69 88

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-A01852-43

Identifier Type: -

Identifier Source: org_study_id